Wolverine Trading’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.9M | Buy |
23,400
+5,200
| +29% | +$635K | ﹤0.01% | 1840 |
|
|
2025
Q2 | $2.18M | Buy |
18,200
+5,600
| +44% | +$631K | ﹤0.01% | 1645 |
|
|
2025
Q1 | $1.42M | Sell |
12,600
-40,400
| -76% | -$4.3M | ﹤0.01% | 1925 |
|
|
2024
Q4 | $5.16M | Buy |
53,000
+36,900
| +229% | +$3.93M | ﹤0.01% | 1186 |
|
|
2024
Q3 | $1.86M | Buy |
+16,100
| New | +$1.83M | ﹤0.01% | 1753 |
|
|
2024
Q2 | – | Sell |
-10,300
| Closed | -$996K | – | 5007 |
|
|
2024
Q1 | $996K | Buy |
10,300
+2,100
| +26% | +$215K | ﹤0.01% | 2207 |
|
|
2023
Q4 | $828K | Sell |
8,200
-23,700
| -74% | -$2.29M | ﹤0.01% | 2477 |
|
|
2023
Q3 | $3.25M | Sell |
31,900
-700
| -2% | -$71.1K | ﹤0.01% | 1271 |
|
|
2023
Q2 | $3.24M | Buy |
32,600
+19,000
| +140% | +$1.9M | ﹤0.01% | 1185 |
|
|
2023
Q1 | $1.25M | Buy |
+13,600
| New | +$1.19M | ﹤0.01% | 1722 |
|
|
2022
Q3 | – | Sell |
-11,700
| Closed | -$992K | – | 5104 |
|
|
2022
Q2 | $992K | Sell |
11,700
-6,300
| -35% | -$553K | ﹤0.01% | 1932 |
|
|
2022
Q1 | $1.58M | Sell |
18,000
-3,600
| -17% | -$312K | ﹤0.01% | 1976 |
|
|
2021
Q4 | $1.89M | Buy |
21,600
+12,800
| +145% | +$1.06M | ﹤0.01% | 1951 |
|
|
2021
Q3 | $729K | Buy |
+8,800
| New | +$792K | ﹤0.01% | 3419 |
|
|
2021
Q2 | – | Sell |
-17,900
| Closed | -$1.56M | – | 6488 |
|
|
2021
Q1 | $1.56M | Buy |
+17,900
| New | +$1.61M | ﹤0.01% | 2212 |
|
|
2020
Q3 | – | Sell |
-68,600
| Closed | -$5.99M | – | 4955 |
|
|
2020
Q2 | $5.99M | Buy |
68,600
+14,300
| +26% | +$1.23M | 0.02% | 712 |
|
|
2020
Q1 | $4.45M | Sell |
54,300
-33,700
| -38% | -$3.01M | 0.01% | 827 |
|
|
2019
Q4 | $8.32M | Buy |
88,000
+33,800
| +62% | +$3.03M | 0.02% | 763 |
|
|
2019
Q3 | $4.74M | Sell |
54,200
-6,500
| -11% | -$584K | 0.01% | 895 |
|
|
2019
Q2 | $5.54M | Buy |
60,700
+7,244
| +14% | +$613K | 0.02% | 827 |
|
|
2019
Q1 | $4.61M | Buy |
53,456
+14,842
| +38% | +$1.19M | 0.01% | 926 |
|
|
2018
Q4 | $2.95M | Buy |
38,614
+13,169
| +52% | +$1.03M | 0.01% | 1137 |
|
|
2018
Q3 | $1.96M | Buy |
+25,445
| New | +$1.88M | ﹤0.01% | 1688 |
|
|
2018
Q1 | – | Sell |
-21,650
| Closed | -$1.63M | – | 5616 |
|
|
2017
Q4 | $1.63M | Buy |
+21,650
| New | +$1.63M | 0.01% | 1715 |
|
|
2017
Q1 | – | Sell |
-63,389
| Closed | -$4.14M | – | 4773 |
|
|
2016
Q4 | $4.14M | Buy |
63,389
+11,607
| +22% | +$753K | 0.02% | 850 |
|
|
2016
Q3 | $3.68M | Sell |
51,782
-11,495
| -18% | -$838K | 0.02% | 927 |
|
|
2016
Q2 | $4.6M | Buy |
+63,277
| New | +$4.37M | 0.03% | 649 |
|
Other funds holding NVS
Wolverine Trading's NVS Position: Q3 2025 in Review
Wolverine Trading reduced its Novartis (NVS) stake by 53% in Q3 2025, selling an estimated $618K and leaving 4,415 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.
Wolverine Trading first reported a position in NVS in Q2 2016 and has held it in 21 quarters since. The position peaked at $5M in Q2 2019. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- Wolverine Trading held 4,415 shares of Novartis worth $548K as of Q3 2025.
- Wolverine Trading sold 5,061 Novartis shares in Q3 2025, an estimated $618K.
- Novartis made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3607 holding.
- Wolverine Trading first reported a position in Novartis in Q2 2016 and has held it in 21 quarters since.
- Wolverine Trading's Novartis position peaked at $5M in Q2 2019.
- 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.